CDK1 and laryngeal carcinoma: Subsequently, sh-FLJ20021 and pcDNA 3.1 or pcDNA-CDK1 were transfected into Hep-2/R cells to determine whether CDK1 was involved in lncRNA FLJ20021-mediated PANoptosis and affected the malignant progression of laryngeal cancer and cisplatin resistance.